Hi, what are you looking for?
Both Perrigo and Teva are down on the Tel Aviv Stock Exchange following the Independence Day break. After US-Israeli pharmaceuticals company Perrigo (PRGO) rejected...
The rejection assists Teva's $41 billion bid for Mylan, which is contingent on the Perrigo deal not going ahead.
Here is our list of the ten most significant Jewish business people of 2014. Some were included for making positive headlines this year. Some...
Here is our list of the ten companies that made the biggest or at least the most headlines this past year, for good...
On Monday, NewLink Genetics announced it has made a deal with drug maker Merck, to research, develop, manufacture and distribute an experimental Ebola vaccine,...
George Soros’ 13F might cause even the most brazen bulls to start to wonder if Soros thinks Armageddon is near. After a 5 year...
– Multiple sclerosis treatment Copaxone accounts for an estimated half of Teva’s profit. – Changes in the multiple sclerosis treatment market, in which...
– My instinctive reaction to Monday’s tragic news was to not write a positive news blog this week. But why let the terrorists win? Dry Bones’ cartoon included...
The Annual Drug Repositioning, Repurposing & Rescue Conference announces Bruce Bloom of Cures Within Reach and Aris Persidis of Biovista as conference chairs.
The Annual Drug Repositioning, Repurposing & Rescue Conference announces Bruce Bloom of Cures Within Reach and Aris Persidis of Biovista as conference chairs.